Research Nester has recently announced new market demand assessment research titled “Transdermal (Non-Invasive) Drug Delivery Market – Global Demand Analysis & Opportunity Outlook 2021”. The global market study provides a granular data and in-depth analysis on the current and future market situations that are crucial for the existing &new players in the market.The industry research is based on key factors like demand & supply analysis, commercial activities, research investments, pricing analysis, government initiatives & guidelines, driving forces in the market, roadblocks and segmentation based on the product viability.
Transdermal patch is a pharmaceutical paste patch that is positioned on the skin to transport a special amount of medicine through the skin into the blood circulation hence make it non- invasive way of drug delivery. Global transdermal drug delivery market was estimated at USD 22.0 Billion in 2010 and reached to at USD 32.0 Billion in 2015, registering a compound annual growth rate (CAGR) of 8.0%.
Global transdermal drug delivery market is estimated at USD 30.3 Billion in 2015 with 12.6% share accounted to the U.S. only; biggest market for transdermal drug delivery in the region. North American total drug delivery market was estimated at USD 518.2 Billion in 2015 and is anticipated to reach USD 752.6 Billion by 2021. Owing to rise in the demand of innovative drug delivery market in this region and growing acceptance of drug delivery technology by pharmaceutical and medical device companies are few of the factors that are projected to drive the transdermal patch drug delivery market in North America.
The European total drug delivery market was valued at USD 39.9 Billion in the year 2012 and it is anticipated that the transdermal drug delivery market will grow at a healthy rate over the forecasted period i.e. 2015-2021 owing to the increasing demand for self-administration and home healthcare devices.
On the back of factors like rising number of transdermal drug delivery products, enhanced awareness in developed nations about non-invasive way of drug administering drugs into body, increasing demand owing to its convenience over other conventional methods for supervising drugs etc. the transdermal patch drug delivery market is expected to have a greater demand in near future. In addition to that, steep rise in diabetic population across the globe, advancement of technology in transdermal drug delivery and rise in the personal disposable income across the world are the factors which are anticipated to drive the growth of global transdermal drug delivery market during the forecasted period i.e. 2015-2021.
- Electric current, Electroporation, Lontophoresis, Mechanical arrays, Microporation, Radio Frequency, Thermal, Ultrasound
Analysis By Types
While studying the global transdermal drug delivery market, we had segregated the market into:
- Electric current
- Mechanical arrays
- Radio Frequency
The key player of the global transdermal drug delivery market is as follows:
- ANI Pharmaceuticals Inc.
- Antares Pharma Inc.
- Bayer AG
- Janssen Pharmaceuticals Inc.
- Novartis AG
- North America (United States / U.S., Canada)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia, Poland, Rest of Eastern Europe)
- Asia-Pacific (China, India, Singapore, Japan, Australia & New Zealand & Rest of Asia)
- Rest of World
To know more on coverage, click on the link below:-
Phone : U.S. +1 646 586 9123
U.K. +44 203 608 5919